* Bausch Health Companies Inc BHC.TO is expected to show
a fall
in quarterly revenue when it reports results on February 23.
* The Laval Quebec-based company is expected to report a
2.7% decrease in revenue to $2.136 billion from $2.2 billion a
year ago, according to the mean estimate from 6 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Bausch Health
Companies
Inc is for earnings of 91 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Bausch
Health
Companies Inc is $8, below its last closing price of C$12.80.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.84 0.87 0.76 Missed -12.6
Jun. 30 2022 0.89 0.89 0.56 Missed -37.3
Mar. 31 2022 1.00 1.03 0.73 Missed -28.9
Dec. 31 2021 1.12 1.11 1.28 Beat 15
Sep. 1.04 1.04 1.16 Beat 11
30 2021
Jun. 30 2021 0.98 0.98 0.97 Missed -1
Mar. 31 2021 0.95 0.95 1.04 Beat 9.1
Dec. 31 2020 1.14 1.14 1.33 Beat 17.1
This summary was machine generated February 21 at 13:44 GMT.
All figures in US dollars unless otherwise stated